Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG in Huntington's Disease
NCT01357681Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2011
- Primary completion
- May 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in Huntington's disease (HD), sponsored by Charité – Universitätsmedizin Berlin. Started Sep 2011; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT01357681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357681.